Retour

Choisissez votre région

Corporate

Demandez un entretien de conseil sur les cellules souches

En savoir plus

Liste des patients
traités

Liste des utilisations des cellules souches approuvées par les laboratoires du groupe Famicord:

Image
Liste des utilisations des cellules souches approuvées par les laboratoires du groupe Famicord:
Nr. Source Type de source Diagnostic Domaine médical Année d’application Thérapie Pays Âge du bénéficiaire
8001 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Poland 15
8002 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Poland 52
8003 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Poland 20
8004 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Poland 60
8005 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Poland 9
8006 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Poland 61
8007 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Poland 63
8008 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Poland 15
8009 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Poland 37
8010 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Poland 59
8011 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Poland 62
8012 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Poland 58
8013 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Poland 69
8014 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Poland 66
8015 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Germany 67
8016 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Germany 57
8017 Apheresis Allogeneic Myelodysplastic Syndrome – Rcmd Hematology 2016 Standard Therapy Poland 32
8018 Apheresis Allogeneic Myelodysplastic Syndrome – Raeb Hematology 2016 Standard Therapy Poland 56
8019 Apheresis Allogeneic Myelofibrosis Hematology 2016 Standard Therapy Poland 72
8020 Apheresis Allogeneic Myelofibrosis Hematology 2016 Standard Therapy Poland 66
8021 Apheresis Allogeneic Myelofibrosis Hematology 2016 Standard Therapy Poland 67
8022 Apheresis Allogeneic Myeloma Multiplex Hematology 2016 Standard Therapy Poland 63
8023 Apheresis Allogeneic Myeloma Multiplex Hematology 2016 Standard Therapy Poland 51
8024 Apheresis Allogeneic Myeloma Multiplex Hematology 2016 Standard Therapy Poland 38
8025 Apheresis Allogeneic Myeloproliferative Syndrome Hematology 2016 Standard Therapy Poland 52
8026 Apheresis Allogeneic Myeloproliferative Syndrome Hematology 2016 Standard Therapy Germany 63
8027 Apheresis Autologous Neuroblastoma Hematology 2016 Standard Therapy Germany 5
8028 Apheresis Allogeneic No Data no data 2016 Standard Therapy Poland 45
8029 Apheresis Allogeneic No Data no data 2016 Standard Therapy Poland 70
8030 Apheresis Allogeneic No Data no data 2016 Standard Therapy Poland 43
8031 Apheresis Allogeneic No Data no data 2016 Standard Therapy Poland 69
8032 Apheresis Allogeneic No Data no data 2016 Standard Therapy Poland 28
8033 Apheresis Allogeneic No Data no data 2016 Standard Therapy Poland 1
8034 Apheresis Allogeneic No Data no data 2016 Standard Therapy Poland 30
8035 Apheresis Allogeneic No Data no data 2016 Standard Therapy Poland 71
8036 Apheresis Allogeneic No Data no data 2016 Standard Therapy Poland 58
8037 Apheresis Allogeneic No Data no data 2016 Standard Therapy Poland 17
8038 Apheresis Allogeneic No Data no data 2016 Standard Therapy Poland 59
8039 Apheresis Allogeneic No Data no data 2016 Standard Therapy Poland 58
8040 Apheresis Allogeneic No Data no data 2016 Standard Therapy Poland 55
8041 Apheresis Allogeneic No Data no data 2016 Standard Therapy Poland 44
8042 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2016 Standard Therapy Poland 38
8043 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2016 Standard Therapy Poland 58
8044 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2016 Standard Therapy Poland 32
8045 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2016 Standard Therapy Poland 39
8046 Apheresis Autologous Non-Hodgkin Lymphoma Hematology 2016 Standard Therapy Germany 61
8047 Apheresis Autologous Non-Hodgkin Lymphoma Hematology 2016 Standard Therapy Germany 73
8048 Apheresis Autologous Non-Hodgkin Lymphoma Hematology 2016 Standard Therapy Germany 27
8049 Apheresis Autologous Non-Hodgkin Lymphoma Hematology 2016 Standard Therapy Germany 65
8050 Apheresis Autologous Non-Hodgkin Lymphoma Hematology 2016 Standard Therapy Germany 61
8051 Apheresis Allogeneic Plasma Cell Disorder Hematology 2016 Standard Therapy Poland 47
8052 Apheresis Autologous Plasmacytoma Hematology 2016 Standard Therapy Germany 58
8053 Apheresis Autologous Plasmacytoma Hematology 2016 Standard Therapy Germany 68
8054 Apheresis Autologous Plasmacytoma Hematology 2016 Standard Therapy Germany 48
8055 Apheresis Autologous Primary Central Nervous System Lymphoma Hematology 2016 Standard Therapy Germany 62
8056 Apheresis Autologous Primary Central Nervous System Lymphoma Hematology 2016 Standard Therapy Germany 51
8057 Apheresis Autologous Primary Central Nervous System Lymphoma Hematology 2016 Standard Therapy Germany 62
8058 Apheresis Allogeneic Primary Immunodeficiency Hematology 2016 Standard Therapy Poland 5
8059 Apheresis Allogeneic Primary Myelofibrosis Hematology 2016 Standard Therapy Poland 50
8060 Apheresis Allogeneic Primary Myelofibrosis Hematology 2016 Standard Therapy Poland 67
8061 Apheresis Allogeneic Primary Myelofibrosis Hematology 2016 Standard Therapy Poland 67
8062 Apheresis Allogeneic Primary Myelofibrosis Hematology 2016 Standard Therapy Germany 56
8063 Apheresis Allogeneic Primary Myelofibrosis Hematology 2016 Standard Therapy Germany 58
8064 Apheresis Allogeneic Refractory Anemia With Excess Blasts Hematology 2016 Standard Therapy Poland 62
8065 Apheresis Allogeneic Severe Aplastic Anemia / Amyloidosis Hematology 2016 Standard Therapy Poland 45
8066 Apheresis Allogeneic Secondary Acute Myeloid Leukemia At Myeloproliferative Syndrome Hematology 2016 Standard Therapy Germany 28
8067 Apheresis Allogeneic Severe Aplastic Anemia Hematology 2016 Standard Therapy Poland 18
8068 Apheresis Autologous Small Cell Ovarian Carcinoma Hematology 2016 Standard Therapy Germany 18
8069 Apheresis Allogeneic T Cell Lymphoma/ Nos – Not Otherwise Specified Hematology 2016 Standard Therapy Poland 55
8070 Apheresis Allogeneic T-Cell Acute Lymphoblastic Leukemia Hematology 2016 Standard Therapy Poland 19
8071 Apheresis Allogeneic T-Cell Acute Lymphoblastic Leukemia Hematology 2016 Standard Therapy Poland 21
8072 Apheresis Allogeneic T-Cell Acute Lymphoblastic Leukemia Hematology 2016 Standard Therapy Poland 41
8073 Apheresis Allogeneic T-Cell Leukemia/Lymphoma Hematology 2016 Standard Therapy Poland 31
8074 Apheresis Autologous T-Cell Non-Hodgkin Lymphoma Hematology 2016 Standard Therapy Germany 48
8075 Apheresis Allogeneic T-Cell Non-Hodgkin Lymphoma Hematology 2016 Standard Therapy Germany 24
8076 Apheresis Autologous T-Cell-Lymphoma Hematology 2016 Standard Therapy Germany 55
8077 Apheresis Autologous T-Cell-Lymphoma Hematology 2016 Standard Therapy Germany 33
8078 Apheresis Allogeneic T-Cell-Prolymphocytic Leukemia Hematology 2016 Standard Therapy Poland 61
8079 Apheresis Allogeneic Wiskott-Aldrich Syndrome Hematology 2016 Standard Therapy Poland 1
8080 Apheresis Allogeneic X-Linked Lymphoproliferative Disease Hematology 2016 Standard Therapy Poland 12
8081 Cord Tissue Allogeneic – Unrelated Acute Graft Versus Host Disease Hematology 2015 Experimental Therapy Poland 1,4
8082 Cord Tissue Allogeneic – Unrelated Acute Graft Versus Host Disease Hematology 2015 Experimental Therapy Poland 11 months
8083 Cord Tissue Allogeneic – Unrelated Acute Graft Versus Host Disease Hematology 2015 Experimental Therapy Poland 51,5
8084 Cord Tissue Allogeneic – Unrelated Acute Graft Versus Host Disease Hematology 2015 Experimental Therapy Poland 6,6
8085 Cord Tissue Allogeneic – Unrelated Acute Graft Versus Host Disease Hematology 2015 Experimental Therapy Poland 13,4
8086 Cord Tissue Allogeneic – Unrelated Adrenoleukodystrophy; Encephalopathy Neurology 2015 Experimental Therapy Poland 23
8087 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2015 Experimental Therapy Poland 61,6
8088 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2015 Experimental Therapy Poland 61
8089 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2015 Experimental Therapy Poland 56
8090 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2015 Experimental Therapy Poland 51
8091 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2015 Experimental Therapy Poland 65
8092 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2015 Experimental Therapy Poland 60
8093 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2015 Experimental Therapy Poland 52
8094 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2015 Experimental Therapy Poland 59,4
8095 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2015 Experimental Therapy Poland 61,5
8096 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2015 Experimental Therapy Poland 58
8097 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2015 Experimental Therapy Poland 61,6
8098 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2015 Experimental Therapy Poland 62
8099 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2015 Experimental Therapy Poland 26,5
8100 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2015 Experimental Therapy Poland 27